Michael Fischbein of the Stanford University Medical Center reviews advances in cardiac surgical procedures including new therapeutic approaches to treat valvular disease, heart failure/heart transplantation, and aortic disease. Discussion will include application of new minimally invasive techniques and potential for stem cell application to treat essential and complex cardiovascular conditions.
Recent Comments